FDA Approves Pfizer Drug to Treat Rheumatoid Arthritis

Published November 13, 2012

FDA approves Pfizer drug to treat rheumatoid arthritis

Filed under: drug treatment news 2012

The drug, Xeljanz, known generically as tofacitinib, is approved to treat adults with moderate to severe arthritis who cannot take, or have an inadequate response to, methotrexate, a standard rheumatoid arthritis treatment. Rheumatoid arthritis is an …
Read more on Reuters

Celsion Corporation Reports Third Quarter 2012 Financial Results and Business …

Filed under: drug treatment news 2012

With positive results from the HEAT Study, we are preparing to introduce the first and most important 1st line drug therapy ever for non-resectable HCC. If successful, we will create substantial value for all of our stakeholders, including the global …
Read more on Equities.com

Nektar Therapeutics receives fast track designation for breast cancer drug

Filed under: drug treatment news 2012

Nov 12, 2012 (Datamonitor via COMTEX) — Nektar Therapeutics, a biopharmaceutical company, has received fast track designation from the FDA for etirinotecan pegol for a development program for the treatment of patients with locally recurrent or …
Read more on Equities.com